Acro Biomedical (ACBM) Operating Margin (2017 - 2022)

Acro Biomedical's Operating Margin history runs 6 years deep, the most recent figure standing at 1092.75% for Q4 2022.

• In Q4 2022, Operating Margin fell 44850.0% year-over-year to 1092.75%; the TTM figure through Sep 2023 stood at 3533.57% (down 177245.0% YoY), while the FY2022 annual figure was 2409.98%, down 176751.0% from the prior year.
• Operating Margin was 1092.75% for Q4 2022 at Acro Biomedical, up from 1316.11% in the prior quarter.
• In the past five years, Operating Margin ranged from a high of 11.85% in Q1 2020 to a low of 1316.11% in Q1 2022.
• Historically, Operating Margin has averaged 298.49% across 5 years, with a median of 38.98% in 2019.
• The sharpest annual moves came in 2018 and 2022: Operating Margin slumped 1251 bps in 2018, then slumped 125883 bps in 2022.
• A 5-year view of Operating Margin shows it stood at 6.96% in 2018, then sank by 460 bps to 38.98% in 2019, then jumped by 130 bps to 11.85% in 2020, then tumbled by 5534 bps to 644.25% in 2021, then sank by 70 bps to 1092.75% in 2022.
• The last three Operating Margin figures came in at 1092.75% (Q4 2022), 1316.11% (Q1 2022), and 644.25% (Q4 2021), per Business Quant data.